Philip Van Kerrebroeck

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. doi Clinical study results of tolterodine in patients with overactive bladder
    Philip Van Kerrebroeck
    University of Maastricht, University Hospital Maastricht, P Debyelaan 25, 6229 HX Maastricht, The Netherlands
    Expert Rev Neurother 3:155-63. 2003
  2. pmc Long-term results of vaginal repairs with and without xenograft reinforcement
    Lone Mouritsen
    Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, 2730 Herlev, Copenhagen, Denmark
    Int Urogynecol J 21:467-73. 2010
  3. ncbi Treatment of stress urinary incontinence: recent developments in the role of urethral injection
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, The Netherlands
    Urol Res 30:356-62. 2003
  4. ncbi Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study
    Philip E V van Kerrebroeck
    Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands
    J Urol 178:2029-34. 2007
  5. ncbi The efficacy and safety of a new once-a-day formulation of an alpha-blocker
    P E Van Kerrebroeck
    Department of Urology in the University Hospital of Maastricht, Maastricht, The Netherlands
    Eur Urol 39:19-26. 2001
  6. ncbi Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents
    P E V van Kerrebroeck
    Department of Urology, Academic Hospital Maastricht, Maastricht, The Netherlands
    BJU Int 89:420-5. 2002
  7. doi Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms
    Philip E V van Kerrebroeck
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Int Urogynecol J 21:S467-74. 2010
  8. doi What treatment should we use if drugs fail for OAB; and, what really works after drugs?
    J L H R Bosch
    Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Neurourol Urodyn 29:658-61. 2010
  9. ncbi Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction
    W A Scheepens
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Urology 60:598-602. 2002
  10. ncbi Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Urology 64:276-81. 2004

Collaborators

Detail Information

Publications24

  1. doi Clinical study results of tolterodine in patients with overactive bladder
    Philip Van Kerrebroeck
    University of Maastricht, University Hospital Maastricht, P Debyelaan 25, 6229 HX Maastricht, The Netherlands
    Expert Rev Neurother 3:155-63. 2003
    ..This review summarizes the primary antimuscarinic profile of tolterodine and reviews the efficacy, safety and tolerability of tolterodine in studies of patients with overactive bladder...
  2. pmc Long-term results of vaginal repairs with and without xenograft reinforcement
    Lone Mouritsen
    Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, 2730 Herlev, Copenhagen, Denmark
    Int Urogynecol J 21:467-73. 2010
    ..The aim of this paper is to study if xenograft reinforcement of vaginal repair reduces recurrence of prolapse...
  3. ncbi Treatment of stress urinary incontinence: recent developments in the role of urethral injection
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, The Netherlands
    Urol Res 30:356-62. 2003
    ..Although few data are yet available, it is conceivable that urethral injection administered 'blind' may in future be considered as an option for all patients failing non-invasive treatment...
  4. ncbi Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study
    Philip E V van Kerrebroeck
    Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands
    J Urol 178:2029-34. 2007
    ..This 5-year, prospective, multicenter trial evaluated the long-term safety and efficacy of sacral neuromodulation in patients with refractory urge incontinence, urgency frequency and retention...
  5. ncbi The efficacy and safety of a new once-a-day formulation of an alpha-blocker
    P E Van Kerrebroeck
    Department of Urology in the University Hospital of Maastricht, Maastricht, The Netherlands
    Eur Urol 39:19-26. 2001
    ..To assess the long-term efficacy and safety of alfuzosin 10 mg OD in patients with symptomatic BPH...
  6. ncbi Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents
    P E V van Kerrebroeck
    Department of Urology, Academic Hospital Maastricht, Maastricht, The Netherlands
    BJU Int 89:420-5. 2002
  7. doi Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms
    Philip E V van Kerrebroeck
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Int Urogynecol J 21:S467-74. 2010
    ..In recent years, other urological indications have been explored...
  8. doi What treatment should we use if drugs fail for OAB; and, what really works after drugs?
    J L H R Bosch
    Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Neurourol Urodyn 29:658-61. 2010
    ..To determine (using structured brain storm sessions), which treatments should be used if drugs fail for OAB and to determine priority research questions in relation to this issue...
  9. ncbi Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction
    W A Scheepens
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Urology 60:598-602. 2002
    ..The advantageous effect of sacral neuromodulation depends on the accurate identification of suitable candidates during the preimplantation PNE...
  10. ncbi Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, Maastricht, The Netherlands
    Urology 64:276-81. 2004
    ..To investigate the efficacy and safety of non-animal-stabilized hyaluronic acid/dextranomer (NASHA/Dx) copolymer for transurethral injection using a new guiding instrument (the Implacer) for stress urinary incontinence...
  11. doi Do patients with OAB experience bladder sensations in the same way as healthy volunteers? A focus group investigation
    R Heeringa
    Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Neurourol Urodyn 31:521-5. 2012
    ....
  12. doi Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms
    P E V van Kerrebroeck
    University Hospital Maastricht, The Netherlands
    Int J Clin Pract 64:584-93. 2010
    ..The aim of this study was to assess the long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder (OAB) symptoms...
  13. ncbi Treatment of stress urinary incontinence using a copolymer system: impact on quality of life
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, The Netherlands
    BJU Int 94:1040-3. 2004
    ..To investigate the effect on quality of life (QoL) of a novel system for treatment of stress urinary incontinence (SUI)...
  14. ncbi The motion: Injectables are justified as a first option for stress urinary incontinence
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, The Netherlands
    Eur Urol 50:857-8; discussion 860. 2006
  15. ncbi Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy
    Christopher R Chapple
    Urology Research Department, J Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK
    Int Urogynecol J Pelvic Floor Dysfunct 18:199-205. 2007
    ..In conclusion, quality-of-life improvements after urethral injection appear significant and comparable to those obtained with surgery. Further study of patients' own perceptions, pre- and posttreatment, would be valuable...
  16. ncbi The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society
    Paul Abrams
    Neurourol Urodyn 21:167-78. 2002
  17. ncbi Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies
    Werner Schäfer
    International Continence Society Office, Southme Hospital, Bristol, BSIO 5NB, United Kingdom
    Neurourol Urodyn 21:261-74. 2002
    ..This does not imply that this technique is the only one possible. Rather, it means that this technique is well-established, and gives good results when used with the suggested standards of good urodynamic practice...
  18. ncbi Efficacy of physical therapeutic modalities in women with proven bladder overactivity
    Bary Berghmans
    Department of Urology, University Hospital Maastricht, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Eur Urol 41:581-7. 2002
    ..To assess the efficacy of physiotherapeutic treatment modalities in women with proven bladder overactivity...
  19. ncbi The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society
    Paul Abrams
    Am J Obstet Gynecol 187:116-26. 2002
  20. ncbi The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society
    Paul Abrams
    Bristol Urological Institute, Bristol, United Kingdom
    Urology 61:37-49. 2003
  21. ncbi Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link?
    Koenraad van Renterghem
    Department of Urology, Virga Jesse Hospital, Stadsomvaart 11, 3500, Hasselt, Belgium
    Int Urol Nephrol 39:1107-13. 2007
    ....
  22. ncbi Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastricht, The Netherlands
    Eur Urol 52:221-9. 2007
    ..To investigate efficacy, safety, and impact on quality of sleep of desmopressin in the treatment of nocturia...
  23. ncbi Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women
    Gunnar Lose
    Department of Gynecology, Glostrup Hospital, Glostrup, Denmark
    Am J Obstet Gynecol 189:1106-13. 2003
    ..The purpose of this study was to investigate the efficacy and safety of oral desmopressin in the treatment of nocturia in women...
  24. ncbi Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastrecht, Netherlands
    BJOG 111:249-57. 2004
    ..To assess the efficacy and safety of duloxetine in women with stress urinary incontinence...